Advertisement

Xofigo® (radium Ra 223 dichloride)

Battle in the Bone

NEW YORK
2018
2018
Entrant Company
Area 23, An FCB Health Network Company
Medium
Print (Pharmaceutical)
Entry Type
Disease Awareness
Thumbnail for Battle in the Bone
View Fullscreen

Items

Credits
Agency NetworkFCB Health Network
Advertiser BrandBayer Pharmaceuticals, Inc./Xofigo® (radium Ra 223 dichloride)
Entrant CompanyArea 23, An FCB Health Network Company
Design CompanyLightfarm
EVP, Managing DirectorTim Hawkey
SVP, Group Creative DirectorBernardo Romero
SVP, Creative DirectorJesse Kates
VP, Associate Creative DirectorDaniel Plansky
VP, Associate Creative DirectorNathaniel Kuritz
Group Art SupervisorSandee Shin
Group Copy SupervisorKatie DeMarco
Associate Director, Print ProductionFrank Laport
Senior Production ManagerLaurette Mercer
SVP, Management DirectorLea Argenti
Account SupervisorMorgan Carey
DirectorMilton Menezes
Creative DirectorRafael Vallaperde
Production ManagerThadeu Felix
VP, Account DirectorDespina Mahles

This 2018 Clio Health Silver winning entry titled 'Battle in the Bone' was entered for Xofigo® (radium Ra 223 dichloride) by Area 23, An FCB Health Network Company, New York, part of agency network: FCB Health Network. The piece was submitted to the medium: Print (Pharmaceutical) within the entry type: Disease Awareness. It consists of 1 image.

Advertisement
Advertisement